Recent News

The Seattle Times published an op-ed by PNRI CEO, Jack Faris, PhD, and Interim Chief Scientific Officer & Senior Investigator, Aimée Dudley, PhD, highlighting the real-world consequences of when federal research funding is disrupted—not just for scientists, but for the millions of people waiting for a diagnosis, treatment, or cure.

Dr. Michael Metzger weighs in on recent research into transmissible cancer in hydras, connecting it to his lab’s work on contagious cancers in shellfish. He shares insights on how these findings contribute to understanding cancer’s evolution across species.

A team of researchers from Baylor College of Medicine, including PNRI’s own Dr. Cláudia Carvalho, conducted a decade-long exploration into Turkish genetics, uncovering a vital piece of the puzzle behind why some rare diseases emerge.

In the ongoing battle for Washington’s official state clam, the Pacific razor clam faces tough competition from geoduck enthusiasts. But amidst the clamor, PNRI scientist Michael Metzger sheds light on the broader challenges these iconic shellfish face due to climate change.

The National Urea Cycle Disorders Foundation (NUCDF) showcased PNRI’s Dudley Lab for its groundbreaking genetic screening tool. The Dudley Lab’s research not only accelerates diagnosis but may also pave the way for personalized treatments, improving patient outcomes.

Carl Zimmer from The New York Times interviewed PNRI’s Dr. Michael Metzger about a study just published in the journal Nature Cancer. Dr. Metzger and a global team of scientists uncovered a transmissible cancer lineage in soft-shell clams more than 200 years old. Their findings not only reshape our understanding of how cancer evolves but offer insights that could help develop novel strategies for blocking cancer in humans and other species.